The increased GzmK expression in the breast cancer tumor microenvironment (TME) corresponds to a high number of antitumor T cells, which is associated with increased overall survival (OS) and recurrence-free survival (RFS) of the patients and increased efficacy of cancer immunotherapy (Figure 5) [330]. The gene discussed is GZMK; the disease is cancer.